Optimizing Outcomes for Relapsed/Refractory CLL/SLL and MCL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

Content Format:

Slideset

Credit Type:

--

Credits:

--
Perspectiva global sobre los datos de tratamientos emergentes con inhibidores de TQB para LLC y LCM en recidiva/refractarios en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Uma perspectiva global sobre os dados emergentes da terapia com inibidor de BTK para LLC e LCM recidivantes/refratários em 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Une perspective globale sur les données émergentes relatives à la thérapie par inhibiteurs BTK chez les patients atteints de LLC ou du LCM récidivant/réfractaire en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Einblicke in neue Daten zu BTK-Inhibitoren bei CLL und MCL der Jahresversammlung der SOHO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Approfondimenti sui nuovi dati relativi agli inibitori di BTK per il trattamento della leucemia linfatica cronica (CLL) e del linfoma mantellare (MCL) come emersi dalla Conferenza annuale della SOHO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Conclusiones sobre los nuevos datos relativos a los inhibidores de la TQB para LLC y LCM de la Junta Anual de SOHO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Insights on New Data With BTK Inhibitors for CLL and MCL From the SOHO 2022 Annual Meeting

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Aperçu des nouvelles données sur les inhibiteurs BTK pour le traitement de la LLC et du LCM à l’occasion de la réunion annuelle de la SOHO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Insights sobre novos dados com inibidores de BTK para LLC e LCM da Reunião Anual da SOHO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--